Short answer · Medically reviewed summary · Last updated: 2026-05-08
Cohen Syndrome is a rare genetic disorder with an estimated prevalence of less than 1 in 100,000 individuals worldwide, though exact figures are difficult to determine due to frequent underdiagnosis. Currently, the condition is considered ultra-rare, with only a few hundred cases documented in medical literature globally. Is Cohen Syndrome considered rare or common? Cohen Syndrome is classified as an ultra-rare multisystem disorder.
2 people with Cohen Syndrome have shared their first-person experience on this question at DiseaseMaps.
What is the prevalence of Cohen Syndrome?
Prevalence of Cohen Syndrome: how many people are affected worldwide, differences by sex and region, with sources.
Cohen Syndrome is a rare genetic disorder with an estimated prevalence of less than 1 in 100,000 individuals worldwide, though exact figures are difficult to determine due to frequent underdiagnosis. Currently, the condition is considered ultra-rare, with only a few hundred cases documented in medical literature globally.
Is Cohen Syndrome considered rare or common?
Cohen Syndrome is classified as an ultra-rare multisystem disorder. Because the clinical presentation can be subtle in early childhood, many individuals may remain undiagnosed or misdiagnosed for years. The limited number of reported cases makes it challenging for epidemiologists to establish precise global prevalence rates.
Are there geographic or ethnic variations in Cohen Syndrome?
While Cohen Syndrome has been reported in diverse populations worldwide, it appears to have a higher frequency in certain groups due to founder effects. Notably, a higher prevalence has been documented in the Finnish population and among specific communities in the Mediterranean region. In the DiseaseMaps.org community, 118 people with Cohen Syndrome have connected to share their experiences, providing a vital real-world perspective that complements clinical data.
What factors affect the accuracy of prevalence data?
Several challenges complicate the tracking of Cohen Syndrome, leading to potential underreporting:
- Diagnostic Complexity: The symptoms, such as intellectual disability and microcephaly, overlap with many other genetic syndromes.
- Genetic Testing Access: Molecular confirmation of VPS13B gene mutations is required for a definitive diagnosis, which may not be accessible in all regions.
- Variable Phenotypes: Some individuals with Cohen Syndrome may have milder manifestations that do not prompt clinical genetic investigation.
How does age and gender impact the condition?
Cohen Syndrome is a lifelong genetic condition, with symptoms typically becoming more apparent as a child grows. There is no significant difference in prevalence between males and females, as the condition is inherited in an autosomal recessive pattern. While often identified in pediatric settings due to developmental delays, the condition persists into adulthood, requiring ongoing multidisciplinary care.
Next steps
- Consult a clinical geneticist to discuss molecular testing if you suspect Cohen Syndrome.
- Connect with the 118 members of the DiseaseMaps.org community to share resources and experiences.
- Review updated clinical guidelines on NIH GARD to stay informed about symptom management.
Medical disclaimer: This information is for educational purposes and should not replace professional medical advice, diagnosis, or treatment.
References
- Orphanet: Cohen Syndrome (ORPHA:193)
- NIH Genetic and Rare Diseases Information Center (GARD)
- OMIM (Online Mendelian Inheritance in Man): #216550
- PubMed/NCBI: Clinical and genetic studies on VPS13B-related disorders.
Posted Sep 8, 2017 by Melodie 2000
Posted Sep 8, 2017 by Emme 1800
